Abstract
Tumour Budding (TB) is recognized as an adverse prognostic factor in colorectal cancer (CRC). TB is the detachment of isolated cancer cells or small clusters of such cells mainly at the invasion front. One question that arises is of the role of the tumour stroma regarding the permissiveness of the formation and progression of TB. In this review, we will examine potential factors affecting TB, in particular we will analyse the potential effect of inflammation, hypoxia, extracellular matrix and Cancer-Associated Fibroblasts (CAFs).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Armin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (eds) (2017) AJCC cancer staging manual, 8th edn. Springer Nature Publishing, ISBN 978-3-319-40617-6
Bronsert P, Enderle-Ammour K, Bader M, Timme S, Kuehs M, Csanadi A, Kayser G, Kohler I, Bausch D, Hoeppner J, Hopt U, Keck T, Stickeler E, Passlick B, Schilling O, Reiss C, Vashist Y, Brabletz T, Berger J, Lotz J, Olesch J, Werner M, Wellner U (2014) Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface: 3D cancer-host interface. J Pathol 234:410–422. https://doi.org/10.1002/path.4416
Calon A, Tauriello DVF, Batlle E (2014) TGF-beta in CAF-mediated tumor growth and metastasis. Semin Cancer Biol 25:15–22. https://doi.org/10.1016/j.semcancer.2013.12.008
Casasent AK, Schalck A, Gao R, Sei E, Long A, Pangburn W, Casasent T, Meric-Bernstam F, Edgerton ME, Navin NE (2018) Multiclonal invasion in breast tumors identified by topographic single cell sequencing. Cell 172:205–217.e12. https://doi.org/10.1016/j.cell.2017.12.007
Centeno I, Paasinen Sohns A, Flury M, Galván JA, Zahnd S, Koelzer VH, Sokol L, Dawson HE, Lugli A, Cathomas G, Zlobec I (2017) DNA profiling of tumor buds in colorectal cancer indicates that they have the same mutation profile as the tumor from which they derive. Virchows Arch 470:341–346. https://doi.org/10.1007/s00428-017-2071-9
Cheung KJ, Padmanaban V, Silvestri V, Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta KJ, Bader JS, Ewald AJ (2016) Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc Natl Acad Sci U S A 113:E854–E863. https://doi.org/10.1073/pnas.1508541113
De Boeck A, Hendrix A, Maynard D, Van Bockstal M, Daniëls A, Pauwels P, Gespach C, Bracke M, De Wever O (2013a) Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression. Proteomics 13:379–388. https://doi.org/10.1002/pmic.201200179
De Boeck A, Pauwels P, Hensen K, Rummens J-L, Westbroek W, Hendrix A, Maynard D, Denys H, Lambein K, Braems G, Gespach C, Bracke M, Wever OD (2013b) Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut 62:550–560. https://doi.org/10.1136/gutjnl-2011-301393
De Smedt L, Palmans S, Andel D, Govaere O, Boeckx B, Smeets D, Galle E, Wouters J, Barras D, Suffiotti M, Dekervel J, Tousseyn T, De Hertogh G, Prenen H, Tejpar S, Lambrechts D, Sagaert X (2017) Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching. Br J Cancer 116:58–65. https://doi.org/10.1038/bjc.2016.382
De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion: stroma and cancer invasion. J Pathol 200:429–447. https://doi.org/10.1002/path.1398
De Wever O, Nguyen Q-D, Van Hoorde L, Bracke M, Bruyneel E, Gespach C, Mareel M (2004) Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 18:1016–1018. https://doi.org/10.1096/fj.03-1110fje
De Wever O, Van Bockstal M, Mareel M, Hendrix A, Bracke M (2014) Carcinoma-associated fibroblasts provide operational flexibility in metastasis. Semin Cancer Biol 25:33–46. https://doi.org/10.1016/j.semcancer.2013.12.009
D’Ignazio L, Batie M, Rocha S (2017) Hypoxia and inflammation in cancer, focus on HIF and NF-κB. Biomedicines 5:21. https://doi.org/10.3390/biomedicines5020021
Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D, Alison MR, Wright NA (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 64:8492–8495. https://doi.org/10.1158/0008-5472.CAN-04-1708
Dvorak HF (1986) Tumors: wounds that do not heal. N Engl J Med 315:1650–1659
EV-TRACK Consortium, Van Deun J, Mestdagh P, Agostinis P, Akay Ö, Anand S, Anckaert J, Martinez ZA, Baetens T, Beghein E, Bertier L, Berx G, Boere J, Boukouris S, Bremer M, Buschmann D, Byrd JB, Casert C, Cheng L, Cmoch A, Daveloose D, De Smedt E, Demirsoy S, Depoorter V, Dhondt B, Driedonks TAP, Dudek A, Elsharawy A, Floris I, Foers AD, Gärtner K, Garg AD, Geeurickx E, Gettemans J, Ghazavi F, Giebel B, Kormelink TG, Hancock G, Helsmoortel H, Hill AF, Hyenne V, Kalra H, Kim D, Kowal J, Kraemer S, Leidinger P, Leonelli C, Liang Y, Lippens L, Liu S, Lo Cicero A, Martin S, Mathivanan S, Mathiyalagan P, Matusek T, Milani G, Monguió-Tortajada M, Mus LM, Muth DC, Németh A, Nolte-’t Hoen ENM, O’Driscoll L, Palmulli R, Pfaffl MW, Primdal-Bengtson B, Romano E, Rousseau Q, Sahoo S, Sampaio N, Samuel M, Scicluna B, Soen B, Steels A, Swinnen JV, Takatalo M, Thaminy S, Théry C, Tulkens J, Van Audenhove I, van der Grein S, Van Goethem A, van Herwijnen MJ, Van Niel G, Van Roy N, Van Vliet AR, Vandamme N, Vanhauwaert S, Vergauwen G, Verweij F, Wallaert A, Wauben M, Witwer KW, Zonneveld MI, De Wever O, Vandesompele J, Hendrix A (2017) EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods 14:228–232. https://doi.org/10.1038/nmeth.4185
Fan X-J, Wan X-B, Yang Z-L, Fu X-H, Huang Y, Chen D-K, Song S-X, Liu Q, Xiao H-Y, Wang L, Wang J-P (2013) Snail promotes lymph node metastasis and twist enhances tumor deposit formation through epithelial-mesenchymal transition in colorectal cancer. Hum Pathol 44:173–180. https://doi.org/10.1016/j.humpath.2012.03.029
Forse CL, Rahimi M, Diamandis EP, Assarzadegan N, Dawson H, Grin A, Kennedy E, O’Connor B, Messenger DE, Riddell RH, Kirsch R, Karagiannis GS (2017) HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer. Exp Mol Pathol 103:94–100. https://doi.org/10.1016/j.yexmp.2017.07.002
Giger OT, Comtesse SCM, Lugli A, Zlobec I, Kurrer MO (2012) Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer. Mod Pathol 25:1048–1053. https://doi.org/10.1038/modpathol.2012.56
Grigore A, Jolly M, Jia D, Farach-Carson M, Levine H (2016) Tumor budding: the name is EMT. Partial EMT. J Clin Med 5:51. https://doi.org/10.3390/jcm5050051
Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P, Bot BM, Morris JS, Simon IM, Gerster S, Fessler E, De Sousa E, Melo F, Missiaglia E, Ramay H, Barras D, Homicsko K, Maru D, Manyam GC, Broom B, Boige V, Perez-Villamil B, Laderas T, Salazar R, Gray JW, Hanahan D, Tabernero J, Bernards R, Friend SH, Laurent-Puig P, Medema JP, Sadanandam A, Wessels L, Delorenzi M, Kopetz S, Vermeulen L, Tejpar S (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21:1350–1356. https://doi.org/10.1038/nm.3967
Haeger A, Krause M, Wolf K, Friedl P (2014) Cell jamming: collective invasion of mesenchymal tumor cells imposed by tissue confinement. Biochim Biophys Acta – Gen Subj 1840:2386–2395. https://doi.org/10.1016/j.bbagen.2014.03.020
Hanley CJ, Mellone M, Ford K, Thirdborough SM, Mellows T, Frampton SJ, Smith DM, Harden E, Szyndralewiez C, Bullock M, Noble F, Moutasim KA, King EV, Vijayanand P, Mirnezami AH, Underwood TJ, Ottensmeier CH, Thomas GJ (2018) Targeting the myofibroblastic cancer-associated fibroblast phenotype through inhibition of NOX4. J Natl Cancer Inst 110:109–120. https://doi.org/10.1093/jnci/djx121
Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102:538–549. https://doi.org/10.1172/JCI1018
Jansen S, Gosens R, Wieland T, Schmidt M (2018) Paving the Rho in cancer metastasis: Rho GTPases and beyond. Pharmacol Ther 183:1–21. https://doi.org/10.1016/j.pharmthera.2017.09.002
Jass JR (2002) HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences. Familial Cancer 3:93–100. https://doi.org/10.1023/B:FAME.0000039849.86008.b7
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. https://doi.org/10.3322/caac.20107
Kalluri R, Weinberg RA (2010) The basics of epithelial-mesenchymal transition. J Clin Invest 120:1786–1786. https://doi.org/10.1172/JCI39104C1
Karagiannis GS, Poutahidis T, Erdman SE, Kirsch R, Riddell RH, Diamandis EP (2012) Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol Cancer Res 10:1403–1418. https://doi.org/10.1158/1541-7786.MCR-12-0307
Karamitopoulou E, Lugli A, Panayiotides I, Karakitsos P, Peros G, Rallis G, Patsouris ES, Terracciano L, Zlobec I (2010) Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer: tumour budding in colorectal cancer. Histopathology 57:233–243. https://doi.org/10.1111/j.1365-2559.2010.03615.x
Koelzer VH, Lugli A, Dawson H, Hädrich M, Berger MD, Borner M, Mallaev M, Galván JA, Amsler J, Schnüriger B, Zlobec I, Inderbitzin D (2014) CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival. J Transl Med 12:81. https://doi.org/10.1186/1479-5876-12-81
Labernadie A, Kato T, Brugués A, Serra-Picamal X, Derzsi S, Arwert E, Weston A, González-Tarragó V, Elosegui-Artola A, Albertazzi L, Alcaraz J, Roca-Cusachs P, Sahai E, Trepat X (2017) A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat Cell Biol 19:224–237. https://doi.org/10.1038/ncb3478
Li H, Xu F, Li S, Zhong A, Meng X, Lai M (2016) The tumor microenvironment: an irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis. Cell Adhes Migr 10:1–13. https://doi.org/10.1080/19336918.2015.1129481
Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M, Wrana JL (2012) Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151:1542–1556. https://doi.org/10.1016/j.cell.2012.11.024
Lugli A, Karamitopoulou E, Panayiotides I, Karakitsos P, Rallis G, Peros G, Iezzi G, Spagnoli G, Bihl M, Terracciano L, Zlobec I (2009) CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer. Br J Cancer 101:1382–1392. https://doi.org/10.1038/sj.bjc.6605318
Lugli A, Vlajnic T, Giger O, Karamitopoulou E, Patsouris ES, Peros G, Terracciano LM, Zlobec I (2011) Intratumoral budding as a potential parameter of tumor progression in mismatch repair–proficient and mismatch repair–deficient colorectal cancer patients. Hum Pathol 42:1833–1840. https://doi.org/10.1016/j.humpath.2011.02.010
Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, El Zimaity H, Fléjou J-F, Hansen TP, Hartmann A, Kakar S, Langner C, Nagtegaal I, Puppa G, Riddell R, Ristimäki A, Sheahan K, Smyrk T, Sugihara K, Terris B, Ueno H, Vieth M, Zlobec I, Quirke P (2017) Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol 30:1299–1311. https://doi.org/10.1038/modpathol.2017.46
Max N, Harbaum L, Pollheimer MJ, Lindtner RA, Kornprat P, Langner C (2016) Tumour budding with and without admixed inflammation: two different sides of the same coin? Br J Cancer 114:368–371. https://doi.org/10.1038/bjc.2015.454
Mertens JC, Fingas CD, Christensen JD, Smoot RL, Bronk SF, Werneburg NW, Gustafson MP, Dietz AB, Roberts LR, Sirica AE, Gores GJ (2013) Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. Cancer Res 73:897–907. https://doi.org/10.1158/0008-5472.CAN-12-2130
Meyer S, Zahnd S, Galván JA, Centeno I, Sokol L, Dawson HE, Koelzer VH, Lugli A, Zlobec I (2016) The search for an epithelial-mesenchymal phenotype in colorectal cancer reveals a subset of cytokeratin-positive/vimentin-positive cells derived from the tumour. Virchows Arch 469:1–346. https://doi.org/10.1007/s00428-016-1997-7
Mlecnik B, Bindea G, Kirilovsky A, Angell HK, Obenauf AC, Tosolini M, Church SE, Maby P, Vasaturo A, Angelova M, Fredriksen T, Mauger S, Waldner M, Berger A, Speicher MR, Pagès F, Valge-Archer V, Galon J (2016) The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis. Sci Transl Med 8:327ra26-327ra26. doi: https://doi.org/10.1126/scitranslmed.aad6352
Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M (1989) An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 63:539–543. https://doi.org/10.1002/1097-0142(19890201)63:3<539::AID-CNCR2820630323>3.0.CO;2-S
Navab R, Strumpf D, Bandarchi B, Zhu C-Q, Pintilie M, Ramnarine VR, Ibrahimov E, Radulovich N, Leung L, Barczyk M, Panchal D, To C, Yun JJ, Der S, Shepherd FA, Jurisica I, Tsao M-S (2011) Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci U S A 108:7160–7165. https://doi.org/10.1073/pnas.1014506108
New J, Arnold L, Ananth M, Alvi S, Thornton M, Werner L, Tawfik O, Dai H, Shnayder Y, Kakarala K, Tsue TT, Girod DA, Ding W-X, Anant S, Thomas SM (2017) Secretory autophagy in cancer-associated fibroblasts promotes head and neck cancer progression and offers a novel therapeutic target. Cancer Res 77:6679–6691. https://doi.org/10.1158/0008-5472.CAN-17-1077
Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335–348. https://doi.org/10.1016/j.cell.2005.02.034
Quante M, Tu SP, Tomita H, Gonda T, Wang SSW, Takashi S, Baik GH, Shibata W, DiPrete B, Betz KS, Friedman R, Varro A, Tycko B, Wang TC (2011) Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 19:257–272. https://doi.org/10.1016/j.ccr.2011.01.020
Righi A, Sarotto I, Casorzo L, Cavalchini S, Frangipane E, Risio M (2015) Tumour budding is associated with hypoxia at the advancing front of colorectal cancer. Histopathology 66:982–990. https://doi.org/10.1111/his.12602
Rogers AC, Gibbons D, Hanly AM, Hyland JM, O’Connell PR, Winter DC, Sheahan K (2014) Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy. Mod Pathol 27:156–162. https://doi.org/10.1038/modpathol.2013.124
Rogers AC, Winter DC, Heeney A, Gibbons D, Lugli A, Puppa G, Sheahan K (2016) Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer. Br J Cancer 115:831–840. https://doi.org/10.1038/bjc.2016.274
Satoh K, Nimura S, Aoki M, Hamasaki M, Koga K, Iwasaki H, Yamashita Y, Kataoka H, Nabeshima K (2014) Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: possible involvement of c-Met. Cancer Sci 105:1487–1495. https://doi.org/10.1111/cas.12530
Tao L, Huang G, Song H, Chen Y, Chen L (2017) Cancer associated fibroblasts: an essential role in the tumor microenvironment. Oncol Lett 14:2611–2620. https://doi.org/10.3892/ol.2017.6497
Te Boekhorst V, Preziosi L, Friedl P (2016) Plasticity of cell migration in vivo and in silico. Ann Rev Cell Dev Biol 32:491–526. https://doi.org/10.1146/annurev-cellbio-111315-125201
Thanki K, Nicholls ME, Gajjar A, Senagore AJ, Qiu S, Szabo C, Hellmich MR, Chao C (2017) Consensus molecular subtypes of colorectal cancer and their clinical implications. Int Biol Biomed J 3:105–111
Trinh A, Lädrach C, Dawson HE, ten Hoorn S, Kuppen P, Reimers MS, Koopman M, Punt C, Lugli A, Vermeulen L, Zlobec I (in press) Tumor budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with consensus. Br J Cancer
Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M (2007) Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 13:2082–2090. https://doi.org/10.1158/1078-0432.CCR-06-2191
Ueno H (2004) Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut 53:581–586. https://doi.org/10.1136/gut.2003.028365
Ulintz PJ, Greenson JK, Wu R, Fearon ER, Hardiman KM (2018) Lymph node metastases in colon cancer are polyclonal. Clin Cancer Res 24:2214–2224. https://doi.org/10.1158/1078-0432.CCR-17-1425
Yang M-H, Wu M-Z, Chiou S-H, Chen P-M, Chang S-Y, Liu C-J, Teng S-C, Wu K-J (2008) Direct regulation of TWIST by HIF-1α promotes metastasis. Nat Cell Biol 10:295–305. https://doi.org/10.1038/ncb1691
Zlobec I, Lugli A (2018) Tumour budding in colorectal cancer: molecular rationale for clinical translation. Nat Rev Cancer 18:203–204. https://doi.org/10.1038/nrc.2018.1
Zlobec I, Hädrich M, Dawson H, Koelzer VH, Borner M, Mallaev M, Schnüriger B, Inderbitzin D, Lugli A (2014) Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients. Br J Cancer 110:1008–1013. https://doi.org/10.1038/bjc.2013.797
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Georges, L.M., Verset, L., Zlobec, I., Demetter, P., De Wever, O. (2018). Impact of the Microenvironment on Tumour Budding in Colorectal Cancer. In: Jordan, P. (eds) Targeted Therapy of Colorectal Cancer Subtypes. Advances in Experimental Medicine and Biology, vol 1110. Springer, Cham. https://doi.org/10.1007/978-3-030-02771-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-02771-1_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-02770-4
Online ISBN: 978-3-030-02771-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)